npj Vaccines (Nov 2022)
Author Correction: A self-amplifying RNA vaccine against COVID-19 with long-term room-temperature stability
- Emily A. Voigt,
- Alana Gerhardt,
- Derek Hanson,
- Madeleine F. Jennewein,
- Peter Battisti,
- Sierra Reed,
- Jasneet Singh,
- Raodoh Mohamath,
- Julie Bakken,
- Samuel Beaver,
- Christopher Press,
- Patrick Soon-Shiong,
- Christopher J. Paddon,
- Christopher B. Fox,
- Corey Casper
Affiliations
- Emily A. Voigt
- RNA Vaccines, Access to Advanced Health Institute (AAHI)
- Alana Gerhardt
- Product Development, Access to Advanced Health Institute (AAHI)
- Derek Hanson
- RNA Vaccines, Access to Advanced Health Institute (AAHI)
- Madeleine F. Jennewein
- RNA Vaccines, Access to Advanced Health Institute (AAHI)
- Peter Battisti
- RNA Vaccines, Access to Advanced Health Institute (AAHI)
- Sierra Reed
- Product Development, Access to Advanced Health Institute (AAHI)
- Jasneet Singh
- RNA Vaccines, Access to Advanced Health Institute (AAHI)
- Raodoh Mohamath
- Formulation Sciences, Access to Advanced Health Institute (AAHI)
- Julie Bakken
- RNA Vaccines, Access to Advanced Health Institute (AAHI)
- Samuel Beaver
- RNA Vaccines, Access to Advanced Health Institute (AAHI)
- Christopher Press
- Product Development, Access to Advanced Health Institute (AAHI)
- Patrick Soon-Shiong
- ImmunityBio, Inc
- Christopher J. Paddon
- Amyris, Inc
- Christopher B. Fox
- Formulation Sciences, Access to Advanced Health Institute (AAHI)
- Corey Casper
- RNA Vaccines, Access to Advanced Health Institute (AAHI)
- DOI
- https://doi.org/10.1038/s41541-022-00578-7
- Journal volume & issue
-
Vol. 7,
no. 1
pp. 1 – 2
Abstract
No abstracts available.
